我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
1 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
进行中（未招募）
100.0%
暂无批准数据
- Pattern hair loss affects an estimated 50 million men and 30 million women in the US, yet no new drugs have been approved since the late 1990s. - Cosmo's topical clascoterone, which blocks the hormone causing hair loss at the follicle, is slated for a US new drug application in Q1 2027. - Veradermics reported positive results for a minoxidil tablet in male-pattern hair loss and promising mid-stage data in women, potentially becoming the first approved pill for female-pattern hair loss. - Absci is developing ABS-201, an AI-designed injectable for pattern hair loss, with interim data expected in the second half of 2026.
